 |
| Fabry Disease: Facts for Patients and their Families |
 |
 |
|
|
United States |
|
The Mount Sinai School of Medicine provides information about symptoms, diagnosis, management, and enzyme replacement therapy. Register for the International Center for Fabry Disease mailing list.
|
 |
| Url: |
|
| Desc: |
Department of Human Genetics - Mount Sinai School of Medicine
|
| |
The Department of Human Genetics is a hybrid basic science and clinical department that offers a broad-based program of instruction, research, and clinical services in human genetics.
|
| Category: |
Conditions and Diseases\ Nutrition and Metabolism Disorders
|
| Link Error: |
Report It
|
| |
|
|
|
| Related Site |
|
|
Fabry Community : Provides information and support for people with Fabry disease, their caregivers and families, and their health care providers.
Liver Amyloidosis : A gross specimen of a liver by Urbana Atlas of Pathology.
Cerebrotendinous Xanthomatosis : A description of this rare disease, its symptoms, diagnosis and treatment.
Wilson's Disease : A definition of this disease, clinical manifestations, diagnosis and treatment.
Facts on Hyponatremia : Article about over-hydration.
Menkes Disease : Medical information including pathophysiology, causes, clinical features, laboratory and histological findings. Also includes images.
Comprehensive Gaucher Treatment Center : Provides clinical evaluations for the diagnosis and treatment of patients with this disease. Information about the disease and the facility.
Gaucher Registry : Longitudinal, observational program that tracks the health outcomes of routine clinical practice for patients with Gaucher disease.
Fabry's Disease : About this disease its symptoms and possible complications, prognosis and treatment.
Heart - Amyloidosis : Picture of the heart affected by amyloidosis by the Urbana Atlas of Pathology.
|
|
|
 |
 |
 |
Approval Expanded for Breast Cancer Drug Tykerb (HealthDay)
HealthDay - MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug
Administration has expanded approval for Tykerb (lapatinib) to include
postmenopausal women with hormone- and HER2-positive advanced breast
cancer who require hormone therapy. |
|
New Drug Slows Advanced Kidney Cancer (HealthDay)
HealthDay - TUESDAY, Jan. 26 (HealthDay News) -- Treating advanced kidney cancer
patients with the drug pazopanib (Votrient) slowed their disease
progression by 54 percent, a new study has found. |
|
|
 |
